Amplifon (OTCMKTS:AMFPF – Get Free Report) and Cosmos Health (NASDAQ:COSM – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, profitability, valuation and risk.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Amplifon and Cosmos Health, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Amplifon | 0 | 2 | 3 | 0 | 2.60 |
| Cosmos Health | 1 | 0 | 0 | 0 | 1.00 |
Volatility & Risk
Amplifon has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500. Comparatively, Cosmos Health has a beta of 4.69, suggesting that its share price is 369% more volatile than the S&P 500.
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Amplifon | $2.71 billion | 0.91 | $103.33 million | $0.37 | 30.30 |
| Cosmos Health | $65.27 million | 0.59 | -$19.15 million | ($0.64) | -0.60 |
Amplifon has higher revenue and earnings than Cosmos Health. Cosmos Health is trading at a lower price-to-earnings ratio than Amplifon, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
12.6% of Cosmos Health shares are held by institutional investors. 26.2% of Cosmos Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares Amplifon and Cosmos Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Amplifon | 3.01% | 15.03% | 4.29% |
| Cosmos Health | -33.08% | -56.88% | -18.03% |
Summary
Amplifon beats Cosmos Health on 10 of the 13 factors compared between the two stocks.
About Amplifon
Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices. It also operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. Amplifon S.p.A. was founded in 1950 and is headquartered in Milan, Italy. Amplifon S.p.A.
About Cosmos Health
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Receive News & Ratings for Amplifon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amplifon and related companies with MarketBeat.com's FREE daily email newsletter.
